The global super disintegrant market is anticipated to grow at a considerable SGR during the forecast year. Super disintegrates are the chemical agent used in medicines for the treatment of various diseases. It works by dissolving quickly in water or saliva when taken directly into the mouth. The major factor driving the growth of the market is the development of generic medicines and the growing adoption of orally disintegrating tablets (ODTs) among patients. Orally disintegrating tablets (ODTs) are tablets made using super disintegrants that dissolve in water very quickly and efficiently provide treatment to the affected area. Orally disintegrating tablets are easy to use for pediatric patients and for those who are having difficulty swallowing. Several key players Introducing new products to remain competitive in the market. For instance, in July 2021, SPI Pharma launched a new orally disintegrating tablet (ODT) called ‘UltraBurst’. The benefit of UltraBurst is that it provided a platform for flash ODTs as they can disintegrate in less than 10 seconds.
Browse the full report description of “Global Super Disintegrant Market Size, Share & Trend Analysis Report by Type (Natural Super Disintegrant and Synthetic Super Disintegrant), by Application (Gastrointestinal Diseases, Neurological Diseases, Cardiovascular Diseases, Oncology, Infectious Diseases, Hematological Diseases, and Inflammatory Diseases), Forecast (202-2028)” at https://www.omrglobal.com/industry-reports/super-disintegrant-market
Furthermore, the increasing prevalence of several infectious diseases including Tuberculosis, Malaria, and Influenza has increased the demand for super disintegrants for the treatment. According to an article published by World Economic Forum in April 2020, around 10 million people were diagnosed with tuberculosis in 2018. The article also says that around 5 million people are infected by influenza every year. In addition, the global number of patients with inflammatory bowel diseases is also increasing. According to an article published on Medscape in April 2020, around 396 per 100,000 people are affected by inflammatory bowel disease per year. The prevalence of several diseases are increasing the demand for super disintegrants for application in treatment, thus, propelling the growth of the global super disintegrant market.
Market Coverage
• The market number available for – 2022-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Type
o By Application
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- Ashland Global Holdings Inc., BASF, DFE Pharma, JRS PHARMA GmbH & Co. KG, Roquette, and Others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Super Disintegrant Market Report Segment
By Type
By Application
Global Super Disintegrant Market Report Segment by Region
North America
• The US
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/super-disintegrant-market